Breast cancers can also be categorized into different subtypes based on the expression levels of the human epidermal growth factor receptor 2 (HER2) and two hormone receptors: estrogen receptor (ER) and progesterone receptor (PR)
It can also help after cosmetic procedures by supporting a calm and orderly healing process
Smart Materials in Medicine is published by Elsevier on behalf of KeAi Communications, an open access publisher based in Beijing
Purity, concentration, and sterility are unverified
PubMed: 33965067 Phase 2a: Weight Loss Efficacy Study (NCT03224429) Study Title: "Efficacy and Safety of Cagrilintide for Weight Management in Adults With Overweight or Obesity" Status: Completed Phase: Phase 2a Enrollment: 706 participants Study Period: 2018-2020 Location: Multi-country (US, Europe) Design: Randomized, double-blind, placebo-controlled Duration: 26 weeks Intervention: Cagrilintide 0.6/1.2/2.4/4.5 mg weekly Population: BMI 30 or 27 with comorbidity, no diabetes Key Results (26 Weeks): Mean Weight Loss: 10.8% at 4.5 mg (highest dose) 8.6% at 2.4 mg 6.0% at 1.2 mg 4.3% at 0.6 mg 3.0% with placebo 10% Weight Loss: 51% (4.5 mg) vs
doi: 10.1016/j.isci.2024.109752
